Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

48,521

570

600

Excaliard Pharmaceuticals

Excaliard is a biotechnology company developing antisense drugs for the local treatment of scarring and other fibrotic diseases.

Acquired by Pfizer on November 22, 2011

Founded: January 01, 2006

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
NarcX	Pharmaceuticals & Biotechnology	Be Part of the Solution - NarcX is the only solution that destroys and dispo ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...

View more competitors»

Date	Round	Amount	Investors
Nov 27, 2007	Series A	$ 15,500,000	Alta Partners RiverVest Proquest Investments

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
Gordon Foulkes	Founder	Unknown to Unknown